nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.0509	0.294	CbGeAlD
Bretylium—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.0342	0.197	CbGeAlD
Bretylium—SLC6A2—nerve—type 2 diabetes mellitus	0.0192	0.111	CbGeAlD
Bretylium—ATP1A1—islet of Langerhans—type 2 diabetes mellitus	0.0105	0.0605	CbGeAlD
Bretylium—ATP1A1—retina—type 2 diabetes mellitus	0.00897	0.0518	CbGeAlD
Bretylium—ATP1A1—nephron tubule—type 2 diabetes mellitus	0.00845	0.0488	CbGeAlD
Bretylium—ATP1A1—cardiovascular system—type 2 diabetes mellitus	0.00759	0.0438	CbGeAlD
Bretylium—ATP1A1—kidney—type 2 diabetes mellitus	0.00742	0.0428	CbGeAlD
Bretylium—ATP1A1—pancreas—type 2 diabetes mellitus	0.00737	0.0426	CbGeAlD
Bretylium—ATP1A1—cortex of kidney—type 2 diabetes mellitus	0.00723	0.0417	CbGeAlD
Bretylium—ATP1A1—Ion transport by P-type ATPases—PLN—type 2 diabetes mellitus	0.007	0.0908	CbGpPWpGaD
Bretylium—ATP1A1—adipose tissue—type 2 diabetes mellitus	0.00669	0.0386	CbGeAlD
Bretylium—Psychotic disorder—Bromocriptine—type 2 diabetes mellitus	0.00609	0.00813	CcSEcCtD
Bretylium—Vertigo—Tolazamide—type 2 diabetes mellitus	0.00604	0.00806	CcSEcCtD
Bretylium—Angina pectoris—Pioglitazone—type 2 diabetes mellitus	0.00598	0.00797	CcSEcCtD
Bretylium—Angina pectoris—Glimepiride—type 2 diabetes mellitus	0.00582	0.00777	CcSEcCtD
Bretylium—Sweating increased—Glimepiride—type 2 diabetes mellitus	0.00582	0.00777	CcSEcCtD
Bretylium—Orthostatic hypotension—Bromocriptine—type 2 diabetes mellitus	0.0057	0.0076	CcSEcCtD
Bretylium—Conjunctivitis—Glipizide—type 2 diabetes mellitus	0.00555	0.00741	CcSEcCtD
Bretylium—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.00549	0.00732	CcSEcCtD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP2A3—type 2 diabetes mellitus	0.00545	0.0708	CbGpPWpGaD
Bretylium—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.00531	0.00708	CcSEcCtD
Bretylium—Lightheadedness—Metformin—type 2 diabetes mellitus	0.00528	0.00705	CcSEcCtD
Bretylium—Lightheadedness—Irbesartan—type 2 diabetes mellitus	0.00498	0.00665	CcSEcCtD
Bretylium—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.00492	0.00656	CcSEcCtD
Bretylium—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00487	0.0065	CcSEcCtD
Bretylium—Sweating increased—Glyburide—type 2 diabetes mellitus	0.0048	0.00641	CcSEcCtD
Bretylium—Flushing—Glipizide—type 2 diabetes mellitus	0.00476	0.00635	CcSEcCtD
Bretylium—Nasal congestion—Metformin—type 2 diabetes mellitus	0.0047	0.00627	CcSEcCtD
Bretylium—ATP1A1—liver—type 2 diabetes mellitus	0.00469	0.0271	CbGeAlD
Bretylium—Hypertension—Repaglinide—type 2 diabetes mellitus	0.00466	0.00621	CcSEcCtD
Bretylium—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00459	0.00613	CcSEcCtD
Bretylium—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.00452	0.00604	CcSEcCtD
Bretylium—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.0044	0.00587	CcSEcCtD
Bretylium—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00439	0.00586	CcSEcCtD
Bretylium—Lethargy—Metformin—type 2 diabetes mellitus	0.00437	0.00583	CcSEcCtD
Bretylium—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.00431	0.00575	CcSEcCtD
Bretylium—Angina pectoris—Gliclazide—type 2 diabetes mellitus	0.00431	0.00575	CcSEcCtD
Bretylium—Orthostatic hypotension—Valsartan—type 2 diabetes mellitus	0.0043	0.00573	CcSEcCtD
Bretylium—Nasal congestion—Losartan—type 2 diabetes mellitus	0.00418	0.00557	CcSEcCtD
Bretylium—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00417	0.00556	CcSEcCtD
Bretylium—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.00416	0.00555	CcSEcCtD
Bretylium—Lightheadedness—Ramipril—type 2 diabetes mellitus	0.00402	0.00537	CcSEcCtD
Bretylium—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00402	0.00536	CcSEcCtD
Bretylium—Vertigo—Glipizide—type 2 diabetes mellitus	0.00401	0.00535	CcSEcCtD
Bretylium—Syncope—Glipizide—type 2 diabetes mellitus	0.004	0.00534	CcSEcCtD
Bretylium—Nausea—Miglitol—type 2 diabetes mellitus	0.00399	0.00532	CcSEcCtD
Bretylium—Affect lability—Irbesartan—type 2 diabetes mellitus	0.00398	0.00531	CcSEcCtD
Bretylium—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.00392	0.00523	CcSEcCtD
Bretylium—ATP1A1—Ion transport by P-type ATPases—ATP2A2—type 2 diabetes mellitus	0.00392	0.0508	CbGpPWpGaD
Bretylium—Sweating increased—Orlistat—type 2 diabetes mellitus	0.00391	0.00522	CcSEcCtD
Bretylium—Hypertension—Glipizide—type 2 diabetes mellitus	0.00385	0.00514	CcSEcCtD
Bretylium—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00384	0.00512	CcSEcCtD
Bretylium—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.00384	0.00512	CcSEcCtD
Bretylium—Mood swings—Irbesartan—type 2 diabetes mellitus	0.00383	0.00511	CcSEcCtD
Bretylium—Anxiety—Glipizide—type 2 diabetes mellitus	0.00379	0.00505	CcSEcCtD
Bretylium—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00376	0.00501	CcSEcCtD
Bretylium—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00373	0.00498	CcSEcCtD
Bretylium—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00372	0.00496	CcSEcCtD
Bretylium—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.00369	0.00493	CcSEcCtD
Bretylium—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.00369	0.00492	CcSEcCtD
Bretylium—Confusional state—Glipizide—type 2 diabetes mellitus	0.00367	0.0049	CcSEcCtD
Bretylium—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.00366	0.00488	CcSEcCtD
Bretylium—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00363	0.00484	CcSEcCtD
Bretylium—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00363	0.00484	CcSEcCtD
Bretylium—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00361	0.00481	CcSEcCtD
Bretylium—Angina pectoris—Metformin—type 2 diabetes mellitus	0.00361	0.00481	CcSEcCtD
Bretylium—Sweating increased—Metformin—type 2 diabetes mellitus	0.00361	0.00481	CcSEcCtD
Bretylium—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00361	0.00481	CcSEcCtD
Bretylium—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.0036	0.0048	CcSEcCtD
Bretylium—Hypertension—Glimepiride—type 2 diabetes mellitus	0.0036	0.0048	CcSEcCtD
Bretylium—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00359	0.00478	CcSEcCtD
Bretylium—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.00358	0.00478	CcSEcCtD
Bretylium—Shock—Glipizide—type 2 diabetes mellitus	0.00358	0.00478	CcSEcCtD
Bretylium—Nasal congestion—Ramipril—type 2 diabetes mellitus	0.00358	0.00478	CcSEcCtD
Bretylium—Anxiety—Glimepiride—type 2 diabetes mellitus	0.00353	0.00471	CcSEcCtD
Bretylium—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.00352	0.0047	CcSEcCtD
Bretylium—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.00352	0.0047	CcSEcCtD
Bretylium—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00349	0.00466	CcSEcCtD
Bretylium—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00348	0.00464	CcSEcCtD
Bretylium—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00348	0.00464	CcSEcCtD
Bretylium—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.00348	0.00464	CcSEcCtD
Bretylium—Confusional state—Glimepiride—type 2 diabetes mellitus	0.00343	0.00457	CcSEcCtD
Bretylium—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.0034	0.00454	CcSEcCtD
Bretylium—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.00338	0.0045	CcSEcCtD
Bretylium—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.00337	0.0045	CcSEcCtD
Bretylium—Syncope—Bromocriptine—type 2 diabetes mellitus	0.00337	0.00449	CcSEcCtD
Bretylium—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00336	0.00449	CcSEcCtD
Bretylium—Vomiting—Acarbose—type 2 diabetes mellitus	0.00335	0.00447	CcSEcCtD
Bretylium—Shock—Glimepiride—type 2 diabetes mellitus	0.00334	0.00446	CcSEcCtD
Bretylium—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.0033	0.00441	CcSEcCtD
Bretylium—Flushing—Gliclazide—type 2 diabetes mellitus	0.00329	0.00439	CcSEcCtD
Bretylium—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00329	0.00438	CcSEcCtD
Bretylium—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00326	0.00435	CcSEcCtD
Bretylium—Nausea—Tolazamide—type 2 diabetes mellitus	0.00326	0.00435	CcSEcCtD
Bretylium—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00325	0.00433	CcSEcCtD
Bretylium—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.00324	0.00433	CcSEcCtD
Bretylium—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00323	0.00431	CcSEcCtD
Bretylium—Angina pectoris—Losartan—type 2 diabetes mellitus	0.0032	0.00427	CcSEcCtD
Bretylium—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00319	0.00425	CcSEcCtD
Bretylium—Nausea—Acarbose—type 2 diabetes mellitus	0.00313	0.00418	CcSEcCtD
Bretylium—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00311	0.00415	CcSEcCtD
Bretylium—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00309	0.00412	CcSEcCtD
Bretylium—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00303	0.00404	CcSEcCtD
Bretylium—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.00303	0.00404	CcSEcCtD
Bretylium—Nausea—Nateglinide—type 2 diabetes mellitus	0.00302	0.00403	CcSEcCtD
Bretylium—Bradycardia—Metformin—type 2 diabetes mellitus	0.00302	0.00403	CcSEcCtD
Bretylium—Shock—Bromocriptine—type 2 diabetes mellitus	0.00302	0.00402	CcSEcCtD
Bretylium—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00301	0.00402	CcSEcCtD
Bretylium—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.003	0.004	CcSEcCtD
Bretylium—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.00298	0.00398	CcSEcCtD
Bretylium—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00298	0.00397	CcSEcCtD
Bretylium—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00288	0.00384	CcSEcCtD
Bretylium—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00288	0.00384	CcSEcCtD
Bretylium—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.00285	0.0038	CcSEcCtD
Bretylium—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00285	0.0038	CcSEcCtD
Bretylium—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00285	0.0038	CcSEcCtD
Bretylium—Confusional state—Glyburide—type 2 diabetes mellitus	0.00283	0.00377	CcSEcCtD
Bretylium—ATP1A1—Preimplantation Embryo—HMGA1—type 2 diabetes mellitus	0.00282	0.0366	CbGpPWpGaD
Bretylium—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.0028	0.00374	CcSEcCtD
Bretylium—Vomiting—Repaglinide—type 2 diabetes mellitus	0.0028	0.00373	CcSEcCtD
Bretylium—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00279	0.00372	CcSEcCtD
Bretylium—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00278	0.00371	CcSEcCtD
Bretylium—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00277	0.0037	CcSEcCtD
Bretylium—Shock—Glyburide—type 2 diabetes mellitus	0.00276	0.00368	CcSEcCtD
Bretylium—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00275	0.00367	CcSEcCtD
Bretylium—Flushing—Metformin—type 2 diabetes mellitus	0.00275	0.00367	CcSEcCtD
Bretylium—Sweating increased—Ramipril—type 2 diabetes mellitus	0.00275	0.00366	CcSEcCtD
Bretylium—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.00275	0.00366	CcSEcCtD
Bretylium—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00273	0.00365	CcSEcCtD
Bretylium—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00271	0.00362	CcSEcCtD
Bretylium—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00271	0.00362	CcSEcCtD
Bretylium—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00269	0.00358	CcSEcCtD
Bretylium—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00268	0.00357	CcSEcCtD
Bretylium—Hypertension—Gliclazide—type 2 diabetes mellitus	0.00266	0.00355	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—TRPC1—type 2 diabetes mellitus	0.00265	0.0344	CbGpPWpGaD
Bretylium—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00262	0.00349	CcSEcCtD
Bretylium—Nausea—Repaglinide—type 2 diabetes mellitus	0.00262	0.00349	CcSEcCtD
Bretylium—Flushing—Irbesartan—type 2 diabetes mellitus	0.0026	0.00346	CcSEcCtD
Bretylium—Vertigo—Valsartan—type 2 diabetes mellitus	0.00255	0.0034	CcSEcCtD
Bretylium—Syncope—Valsartan—type 2 diabetes mellitus	0.00254	0.00339	CcSEcCtD
Bretylium—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00254	0.00339	CcSEcCtD
Bretylium—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00253	0.00337	CcSEcCtD
Bretylium—Vertigo—Orlistat—type 2 diabetes mellitus	0.00252	0.00336	CcSEcCtD
Bretylium—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00251	0.00335	CcSEcCtD
Bretylium—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.0025	0.00333	CcSEcCtD
Bretylium—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00249	0.00332	CcSEcCtD
Bretylium—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00249	0.00332	CcSEcCtD
Bretylium—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00247	0.0033	CcSEcCtD
Bretylium—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.00244	0.00326	CcSEcCtD
Bretylium—Flushing—Losartan—type 2 diabetes mellitus	0.00244	0.00326	CcSEcCtD
Bretylium—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00243	0.00325	CcSEcCtD
Bretylium—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00242	0.00323	CcSEcCtD
Bretylium—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00242	0.00323	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—PLN—type 2 diabetes mellitus	0.00242	0.0314	CbGpPWpGaD
Bretylium—Dizziness—Glipizide—type 2 diabetes mellitus	0.00241	0.00321	CcSEcCtD
Bretylium—Anxiety—Valsartan—type 2 diabetes mellitus	0.0024	0.00321	CcSEcCtD
Bretylium—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00239	0.00318	CcSEcCtD
Bretylium—Anxiety—Orlistat—type 2 diabetes mellitus	0.00238	0.00317	CcSEcCtD
Bretylium—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00233	0.0031	CcSEcCtD
Bretylium—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00232	0.00309	CcSEcCtD
Bretylium—Vomiting—Glipizide—type 2 diabetes mellitus	0.00232	0.00309	CcSEcCtD
Bretylium—Syncope—Metformin—type 2 diabetes mellitus	0.00231	0.00309	CcSEcCtD
Bretylium—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00231	0.00308	CcSEcCtD
Bretylium—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00231	0.00308	CcSEcCtD
Bretylium—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00229	0.00306	CcSEcCtD
Bretylium—Shock—Valsartan—type 2 diabetes mellitus	0.00228	0.00304	CcSEcCtD
Bretylium—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00227	0.00303	CcSEcCtD
Bretylium—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00225	0.003	CcSEcCtD
Bretylium—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00224	0.00299	CcSEcCtD
Bretylium—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00224	0.00299	CcSEcCtD
Bretylium—Hypertension—Metformin—type 2 diabetes mellitus	0.00223	0.00297	CcSEcCtD
Bretylium—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00222	0.00296	CcSEcCtD
Bretylium—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00221	0.00295	CcSEcCtD
Bretylium—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00219	0.00292	CcSEcCtD
Bretylium—Syncope—Irbesartan—type 2 diabetes mellitus	0.00218	0.00291	CcSEcCtD
Bretylium—Nausea—Glipizide—type 2 diabetes mellitus	0.00216	0.00289	CcSEcCtD
Bretylium—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00216	0.00288	CcSEcCtD
Bretylium—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00215	0.00287	CcSEcCtD
Bretylium—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00214	0.00286	CcSEcCtD
Bretylium—Hypertension—Irbesartan—type 2 diabetes mellitus	0.0021	0.0028	CcSEcCtD
Bretylium—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.0021	0.0028	CcSEcCtD
Bretylium—Flushing—Ramipril—type 2 diabetes mellitus	0.0021	0.00279	CcSEcCtD
Bretylium—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00207	0.00277	CcSEcCtD
Bretylium—Shock—Metformin—type 2 diabetes mellitus	0.00207	0.00276	CcSEcCtD
Bretylium—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00207	0.00276	CcSEcCtD
Bretylium—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00206	0.00275	CcSEcCtD
Bretylium—Vertigo—Losartan—type 2 diabetes mellitus	0.00206	0.00275	CcSEcCtD
Bretylium—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00206	0.00275	CcSEcCtD
Bretylium—Syncope—Losartan—type 2 diabetes mellitus	0.00206	0.00274	CcSEcCtD
Bretylium—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00204	0.00272	CcSEcCtD
Bretylium—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00203	0.00271	CcSEcCtD
Bretylium—Nausea—Glimepiride—type 2 diabetes mellitus	0.00202	0.00269	CcSEcCtD
Bretylium—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00201	0.00269	CcSEcCtD
Bretylium—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00201	0.00268	CcSEcCtD
Bretylium—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00199	0.00265	CcSEcCtD
Bretylium—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00199	0.00265	CcSEcCtD
Bretylium—Shock—Irbesartan—type 2 diabetes mellitus	0.00196	0.00261	CcSEcCtD
Bretylium—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00195	0.0026	CcSEcCtD
Bretylium—Anxiety—Losartan—type 2 diabetes mellitus	0.00194	0.00259	CcSEcCtD
Bretylium—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00192	0.00256	CcSEcCtD
Bretylium—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00192	0.00256	CcSEcCtD
Bretylium—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00189	0.00252	CcSEcCtD
Bretylium—Confusional state—Losartan—type 2 diabetes mellitus	0.00189	0.00252	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.00189	0.0245	CbGpPWpGaD
Bretylium—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00188	0.00251	CcSEcCtD
Bretylium—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00188	0.0025	CcSEcCtD
Bretylium—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00187	0.00249	CcSEcCtD
Bretylium—Shock—Losartan—type 2 diabetes mellitus	0.00184	0.00245	CcSEcCtD
Bretylium—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00183	0.00244	CcSEcCtD
Bretylium—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00182	0.00243	CcSEcCtD
Bretylium—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00181	0.00241	CcSEcCtD
Bretylium—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00181	0.00241	CcSEcCtD
Bretylium—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00181	0.00241	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00179	0.0232	CbGpPWpGaD
Bretylium—Vomiting—Glyburide—type 2 diabetes mellitus	0.00178	0.00238	CcSEcCtD
Bretylium—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00177	0.00236	CcSEcCtD
Bretylium—Vertigo—Ramipril—type 2 diabetes mellitus	0.00177	0.00236	CcSEcCtD
Bretylium—Syncope—Ramipril—type 2 diabetes mellitus	0.00176	0.00235	CcSEcCtD
Bretylium—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00174	0.00232	CcSEcCtD
Bretylium—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00173	0.0023	CcSEcCtD
Bretylium—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00172	0.0023	CcSEcCtD
Bretylium—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00172	0.0023	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.00172	0.0223	CbGpPWpGaD
Bretylium—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00167	0.00222	CcSEcCtD
Bretylium—Anxiety—Ramipril—type 2 diabetes mellitus	0.00167	0.00222	CcSEcCtD
Bretylium—Nausea—Glyburide—type 2 diabetes mellitus	0.00167	0.00222	CcSEcCtD
Bretylium—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00167	0.00222	CcSEcCtD
Bretylium—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00166	0.00222	CcSEcCtD
Bretylium—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00164	0.00218	CcSEcCtD
Bretylium—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00163	0.00217	CcSEcCtD
Bretylium—Confusional state—Ramipril—type 2 diabetes mellitus	0.00162	0.00216	CcSEcCtD
Bretylium—Vomiting—Gliclazide—type 2 diabetes mellitus	0.0016	0.00213	CcSEcCtD
Bretylium—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00158	0.00211	CcSEcCtD
Bretylium—Shock—Ramipril—type 2 diabetes mellitus	0.00158	0.0021	CcSEcCtD
Bretylium—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00157	0.0021	CcSEcCtD
Bretylium—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00157	0.0021	CcSEcCtD
Bretylium—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00156	0.00209	CcSEcCtD
Bretylium—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00155	0.00207	CcSEcCtD
Bretylium—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00154	0.00206	CcSEcCtD
Bretylium—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00153	0.00204	CcSEcCtD
Bretylium—Dizziness—Valsartan—type 2 diabetes mellitus	0.00153	0.00204	CcSEcCtD
Bretylium—Dizziness—Orlistat—type 2 diabetes mellitus	0.00151	0.00202	CcSEcCtD
Bretylium—Nausea—Gliclazide—type 2 diabetes mellitus	0.0015	0.00199	CcSEcCtD
Bretylium—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00148	0.00197	CcSEcCtD
Bretylium—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00148	0.00197	CcSEcCtD
Bretylium—Vomiting—Valsartan—type 2 diabetes mellitus	0.00147	0.00196	CcSEcCtD
Bretylium—Vomiting—Orlistat—type 2 diabetes mellitus	0.00145	0.00194	CcSEcCtD
Bretylium—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00144	0.00192	CcSEcCtD
Bretylium—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00143	0.00191	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00143	0.0186	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.00141	0.0183	CbGpPWpGaD
Bretylium—Dizziness—Metformin—type 2 diabetes mellitus	0.00139	0.00186	CcSEcCtD
Bretylium—Nausea—Valsartan—type 2 diabetes mellitus	0.00137	0.00183	CcSEcCtD
Bretylium—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00136	0.00181	CcSEcCtD
Bretylium—Nausea—Orlistat—type 2 diabetes mellitus	0.00136	0.00181	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.00136	0.0176	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.00135	0.0176	CbGpPWpGaD
Bretylium—Vomiting—Metformin—type 2 diabetes mellitus	0.00134	0.00179	CcSEcCtD
Bretylium—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00132	0.00176	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.00131	0.0171	CbGpPWpGaD
Bretylium—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00131	0.00175	CcSEcCtD
Bretylium—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00131	0.00175	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.00129	0.0167	CbGpPWpGaD
Bretylium—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00128	0.00171	CcSEcCtD
Bretylium—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00127	0.00169	CcSEcCtD
Bretylium—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00127	0.00169	CcSEcCtD
Bretylium—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00126	0.00169	CcSEcCtD
Bretylium—Nausea—Metformin—type 2 diabetes mellitus	0.00125	0.00167	CcSEcCtD
Bretylium—Dizziness—Losartan—type 2 diabetes mellitus	0.00124	0.00165	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00122	0.0158	CbGpPWpGaD
Bretylium—Vomiting—Losartan—type 2 diabetes mellitus	0.00119	0.00159	CcSEcCtD
Bretylium—Nausea—Irbesartan—type 2 diabetes mellitus	0.00118	0.00157	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—AGT—type 2 diabetes mellitus	0.00112	0.0145	CbGpPWpGaD
Bretylium—Nausea—Losartan—type 2 diabetes mellitus	0.00111	0.00148	CcSEcCtD
Bretylium—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.0011	0.00146	CcSEcCtD
Bretylium—Dizziness—Ramipril—type 2 diabetes mellitus	0.00106	0.00141	CcSEcCtD
Bretylium—Vomiting—Ramipril—type 2 diabetes mellitus	0.00102	0.00136	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000976	0.0127	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000954	0.0124	CbGpPWpGaD
Bretylium—Nausea—Ramipril—type 2 diabetes mellitus	0.000953	0.00127	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000925	0.012	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000921	0.012	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000921	0.012	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000843	0.0109	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000812	0.0105	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000784	0.0102	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000769	0.00998	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000751	0.00975	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000751	0.00975	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000723	0.00939	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000723	0.00939	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.00071	0.00922	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000687	0.00892	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000667	0.00866	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000656	0.00852	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000639	0.0083	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000618	0.00803	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000615	0.00799	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000615	0.00798	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000594	0.00771	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000569	0.00739	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000523	0.00679	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000517	0.00671	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TNF—type 2 diabetes mellitus	0.000508	0.00659	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000505	0.00656	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000495	0.00643	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000494	0.00641	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000472	0.00612	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000472	0.00612	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00046	0.00598	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000458	0.00594	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000455	0.00591	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000431	0.0056	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000425	0.00552	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000421	0.00546	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000413	0.00536	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000401	0.00521	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000401	0.00521	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000399	0.00518	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000399	0.00518	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000396	0.00514	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000392	0.00509	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000383	0.00497	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000382	0.00496	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000367	0.00476	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000364	0.00473	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000326	0.00423	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000325	0.00422	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000325	0.00422	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000316	0.0041	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000315	0.00409	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000313	0.00406	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000313	0.00406	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000312	0.00405	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000312	0.00405	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000307	0.00399	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000301	0.00391	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000284	0.00369	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000282	0.00366	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000266	0.00345	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000265	0.00345	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000257	0.00333	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000254	0.0033	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000246	0.0032	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000238	0.0031	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000214	0.00277	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000204	0.00265	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000204	0.00265	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000199	0.00259	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000198	0.00257	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000197	0.00256	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000189	0.00245	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000173	0.00225	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000165	0.00215	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.000161	0.0021	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000161	0.00209	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000159	0.00206	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000137	0.00178	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000136	0.00177	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000135	0.00175	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.00013	0.00169	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000122	0.00158	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.00011	0.00143	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000103	0.00134	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.17e-05	0.00106	CbGpPWpGaD
